annual retained earnings:
-$2.18B-$519.02M(-31.30%)Summary
- As of today (July 27, 2025), NTLA annual retained earnings is -$2.18 billion, with the most recent change of -$519.02 million (-31.30%) on December 31, 2024.
- During the last 3 years, NTLA annual retained earnings has fallen by -$1.47 billion (-209.73%).
- NTLA annual retained earnings is now -22726.29% below its all-time high of -$9.54 million, reached on December 31, 2014.
Performance
NTLA Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$2.29B-$114.33M(-5.25%)Summary
- As of today (July 27, 2025), NTLA quarterly retained earnings is -$2.29 billion, with the most recent change of -$114.33 million (-5.25%) on March 31, 2025.
- Over the past year, NTLA quarterly retained earnings has dropped by -$525.91 million (-29.78%).
- NTLA quarterly retained earnings is now -10347.34% below its all-time high of -$21.94 million, reached on December 31, 2015.
Performance
NTLA quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NTLA Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.3% | -29.8% |
| 3 y3 years | -209.7% | -169.7% |
| 5 y5 years | -623.7% | -588.9% |
NTLA Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -209.7% | at low | -141.1% | at low |
| 5 y | 5-year | -623.7% | at low | -527.7% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
NTLA Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$2.29B(+5.3%) |
| Dec 2024 | -$2.18B(+31.3%) | -$2.18B(+6.3%) |
| Sep 2024 | - | -$2.05B(+7.1%) |
| Jun 2024 | - | -$1.91B(+8.3%) |
| Mar 2024 | - | -$1.77B(+6.5%) |
| Dec 2023 | -$1.66B(+40.9%) | -$1.66B(+8.7%) |
| Sep 2023 | - | -$1.53B(+8.7%) |
| Jun 2023 | - | -$1.40B(+9.7%) |
| Mar 2023 | - | -$1.28B(+8.8%) |
| Dec 2022 | -$1.18B(+67.5%) | -$1.18B(+10.7%) |
| Sep 2022 | - | -$1.06B(+11.9%) |
| Jun 2022 | - | -$950.55M(+11.8%) |
| Mar 2022 | - | -$849.87M(+20.9%) |
| Dec 2021 | -$703.00M(+61.6%) | -$703.00M(+13.1%) |
| Sep 2021 | - | -$621.76M(+13.0%) |
| Jun 2021 | - | -$550.12M(+14.3%) |
| Mar 2021 | - | -$481.31M(+10.6%) |
| Dec 2020 | -$435.11M | -$435.11M(+10.7%) |
| Sep 2020 | - | -$392.92M(+7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -$365.08M(+9.7%) |
| Mar 2020 | - | -$332.68M(+10.6%) |
| Dec 2019 | -$300.88M(+49.7%) | -$300.88M(+10.4%) |
| Sep 2019 | - | -$272.60M(+9.5%) |
| Jun 2019 | - | -$248.97M(+11.5%) |
| Mar 2019 | - | -$223.28M(+11.1%) |
| Dec 2018 | -$201.03M(+66.0%) | -$201.03M(+10.5%) |
| Sep 2018 | - | -$181.96M(+14.3%) |
| Jun 2018 | - | -$159.26M(+16.2%) |
| Mar 2018 | - | -$137.04M(+13.1%) |
| Dec 2017 | -$121.11M(+126.1%) | -$121.11M(+24.7%) |
| Sep 2017 | - | -$97.15M(+18.8%) |
| Jun 2017 | - | -$81.79M(+23.6%) |
| Mar 2017 | - | -$66.20M(+23.6%) |
| Dec 2016 | -$53.57M(+144.2%) | -$53.57M(+24.6%) |
| Sep 2016 | - | -$43.01M(+21.1%) |
| Jun 2016 | - | -$35.52M(+24.1%) |
| Mar 2016 | - | -$28.63M(+30.5%) |
| Dec 2015 | -$21.94M(+130.0%) | -$21.94M |
| Dec 2014 | -$9.54M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual retained earnings?
- What is the all time high annual retained earnings for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual retained earnings year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly retained earnings?
- What is the all time high quarterly retained earnings for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly retained earnings year-on-year change?
What is Intellia Therapeutics, Inc. annual retained earnings?
The current annual retained earnings of NTLA is -$2.18B
What is the all time high annual retained earnings for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual retained earnings is -$9.54M
What is Intellia Therapeutics, Inc. annual retained earnings year-on-year change?
Over the past year, NTLA annual retained earnings has changed by -$519.02M (-31.30%)
What is Intellia Therapeutics, Inc. quarterly retained earnings?
The current quarterly retained earnings of NTLA is -$2.29B
What is the all time high quarterly retained earnings for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly retained earnings is -$21.94M
What is Intellia Therapeutics, Inc. quarterly retained earnings year-on-year change?
Over the past year, NTLA quarterly retained earnings has changed by -$525.91M (-29.78%)